Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATCH-AMI: Balixafortide in STEMI
NCT01905475Phase 2Completed
- Sponsor
- Polyphor
- Start
- Jul 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules, Modified Peptides
- Countries
- 5
01
Overview
A Phase 2 trial of balixafortide in ST elevation myocardial infarction (STEMI), sponsored by Polyphor. Started Jul 2013; status: completed.
02
Drugs
balixafortide
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01905475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01905475.